FUROSCIX
NDC 71767-111, furosemide, injection, from scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation.
- Product NDC
- 71767-111
- Status
- Listed
- Labeler
- scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209988
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71767-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FUROSEMIDE80 mg/mL
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71767-111-01 | 71767011101 | 1 SYRINGE, GLASS in 1 CARTON (71767-111-01) / 1 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/eac958dd-8d43-e44e-e053-2995a90a4d5e
Use it
Look up 71767-111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71767-111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71767-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.